Conversely, bioinformatics data in our study revealed that H19 had as many as 41 possible m6A modification sites, among which 13 were sites of high confidence sites and six were sites of very high confidence, demonstrating that H19 was a possible major lncRNA molecule modified by m6A in the pathological process of atherosclerosis. The gene discussed is H19; the disease is atherosclerosis.